[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX2009004439A - Composicion de ibuprofeno. - Google Patents

Composicion de ibuprofeno.

Info

Publication number
MX2009004439A
MX2009004439A MX2009004439A MX2009004439A MX2009004439A MX 2009004439 A MX2009004439 A MX 2009004439A MX 2009004439 A MX2009004439 A MX 2009004439A MX 2009004439 A MX2009004439 A MX 2009004439A MX 2009004439 A MX2009004439 A MX 2009004439A
Authority
MX
Mexico
Prior art keywords
water
soluble acid
ibuprofen composition
ibuprofen
water soluble
Prior art date
Application number
MX2009004439A
Other languages
English (en)
Inventor
Robert Shen
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of MX2009004439A publication Critical patent/MX2009004439A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención se refiere a una tableta de liberación inmediata capaz de ser masticada o desintegrada en la cavidad oral, que comprende una pluralidad de partículas en una matriz; las partículas contienen un ingrediente activo, tal como ibuprofeno, y un primer ácido soluble en agua que tiene una solubilidad mayor que aproximadamente 10 g/100 ml de agua a 20°C; y la matriz contiene un segundo ácido soluble en agua que tiene una solubilidad menor que aproximadamente 5 g/100 ml de agua a 20°C.
MX2009004439A 2006-10-25 2007-10-24 Composicion de ibuprofeno. MX2009004439A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85434906P 2006-10-25 2006-10-25
PCT/US2007/082348 WO2008052033A2 (en) 2006-10-25 2007-10-24 Ibuprofen composition

Publications (1)

Publication Number Publication Date
MX2009004439A true MX2009004439A (es) 2009-05-11

Family

ID=39223093

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004439A MX2009004439A (es) 2006-10-25 2007-10-24 Composicion de ibuprofeno.

Country Status (8)

Country Link
US (1) US20080113021A1 (es)
EP (1) EP2094248A2 (es)
CN (1) CN101528205A (es)
AU (1) AU2007308986A1 (es)
BR (1) BRPI0718428A2 (es)
CA (1) CA2667207A1 (es)
MX (1) MX2009004439A (es)
WO (1) WO2008052033A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2853262T3 (en) 2009-10-26 2017-03-06 Sephoris Pharmaceuticals Llc Treatment of sunburn using analgesics and antihistamines
US20130217774A1 (en) * 2010-10-24 2013-08-22 Vivekanandan Sundaramoorthy Novel process for preparing dexibuprofen ready to compress granules
CN102258490B (zh) * 2011-07-01 2012-10-03 中美天津史克制药有限公司 布洛芬咀嚼片
CN103826616B (zh) 2011-07-07 2016-08-10 爱尔兰詹森科学公司 地瑞纳韦组合配制品
CN102488681B (zh) * 2011-12-21 2013-03-13 西南大学 布洛芬苯海拉明口腔崩解片及其制备方法
EP2897646A1 (en) * 2012-09-18 2015-07-29 McNeil-PPC, Inc. Sustained release oral dosage forms comprising low melting propionic acid derivative particles
BR112015005876A2 (pt) 2012-09-18 2017-07-04 Mcneil Ppc Inc partículas derivadas de ácido propiônico com baixo ponto de fusão para uso em formas de dosagem oral
JP6282676B2 (ja) * 2013-03-14 2018-02-21 レッド ヒル バイオファーマ リミテッドＲｅｄＨｉｌｌ Ｂｉｏｐｈａｒｍａ Ｌｔｄ． 制吐作用のある徐放性固形製剤
WO2015136377A2 (en) 2014-03-11 2015-09-17 Redhill Biopharma Ltd. Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms
WO2015157729A1 (en) * 2014-04-11 2015-10-15 Wilmink Michael Pharmaceutical formulations an comprising analgesic agent, a nonsteroidal anti-inflammatory agent, a gastric acid production suppressant and an anti-nauseant
IL254641B2 (en) 2015-03-26 2024-01-01 Jacqueline M Iversen Methods and preparations including naproxen and fexofenamide for relieving symptoms of dizziness associated with alcohol consumption
EP3398587B1 (en) * 2015-12-28 2023-08-02 SSP Co., Ltd., Japan Compacted pharmaceutical preparation
CN111035764B (zh) * 2018-10-14 2021-09-07 深圳市健元医药科技有限公司 一种治疗类风湿性关节炎的组合物及其制备方法
WO2020169989A1 (en) 2019-02-22 2020-08-27 Catalent U.K. Swindon Zydis Limited Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising ibuprofen
AR118419A1 (es) * 2019-02-22 2021-10-06 Catalent Uk Swindon Zydis Ltd Minimización de aglomeración de material de revestimiento de partícula de medicamento durante el almacenaje para estabilizar los tiempos de desintegración de productos farmacéuticos
GB2585411B (en) 2019-02-22 2023-10-04 Catalent Uk Swindon Zydis Ltd Preserving functionally-coated API particles produced by solventless mixing processes in aqueous suspension
JP2022521319A (ja) * 2019-02-22 2022-04-06 キャタレント・ユーケー・スウィンドン・ザイディス・リミテッド インライン混合中の懸濁液の通気の最小化

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54127247A (en) * 1978-03-27 1979-10-03 Toshiba Corp Microprogram controller
US4543370A (en) * 1979-11-29 1985-09-24 Colorcon, Inc. Dry edible film coating composition, method and coating form
US4683256A (en) * 1980-11-06 1987-07-28 Colorcon, Inc. Dry edible film coating composition, method and coating form
US4828841A (en) * 1984-07-24 1989-05-09 Colorcon, Inc. Maltodextrin coating
US4643894A (en) * 1984-07-24 1987-02-17 Colorcon, Inc. Maltodextrin coating
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
US4802924A (en) * 1986-06-19 1989-02-07 Colorcon, Inc. Coatings based on polydextrose for aqueous film coating of pharmaceutical food and confectionary products
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4867983A (en) * 1987-02-20 1989-09-19 Mcneilab, Inc. Method for double dipping gelating coated caplets
US4820524A (en) * 1987-02-20 1989-04-11 Mcneilab, Inc. Gelatin coated caplets and process for making same
US4966771A (en) * 1987-02-20 1990-10-30 Mcneilab, Inc. Gelatin coated caplets and process for making same
US4906478A (en) * 1988-12-12 1990-03-06 Valentine Enterprises, Inc. Simethicone/calcium silicate composition
US5275822A (en) * 1989-10-19 1994-01-04 Valentine Enterprises, Inc. Defoaming composition
IT1246383B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per il mascheramento del sapore di farmaci
US5089270A (en) * 1990-05-15 1992-02-18 L. Perrigo Company Capsule-shaped tablet
US5213738A (en) * 1990-05-15 1993-05-25 L. Perrigo Company Method for making a capsule-shaped tablet
US5409709A (en) * 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
AU674840B2 (en) * 1992-01-17 1997-01-16 Bpsi Holdings, Inc. Film coatings and film coating compositions based on cellulosic polymers and lactose
US5466865A (en) * 1993-07-02 1995-11-14 Ibah, Inc. Neomorphic ibuprofen and methods of using same
US6103260A (en) * 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
NZ333474A (en) * 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
US6274162B1 (en) * 2000-01-14 2001-08-14 Bpsi Holdings, Inc. Elegant film coating system
US7223421B2 (en) * 2000-06-30 2007-05-29 Mcneil-Ppc, Inc. Teste masked pharmaceutical particles
US6440983B1 (en) * 2000-12-21 2002-08-27 Mary Theresa Frank-Kollman Compositions and methods for relieving headache symptoms in aspirin-sensitive headache sufferers
AU2002244865A1 (en) * 2001-03-02 2002-09-19 Dr. Reddy's Laboratories Ltd. Pharmaceutical composition of ibuprofen
GB0113843D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
US6982094B2 (en) * 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US7122143B2 (en) * 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
WO2003026626A2 (en) * 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Modified release dosage forms
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
RU2008116871A (ru) * 2005-11-02 2009-12-10 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. (US) Органолептически приемлемые пероральные лекарственные формы ибупрофена, способы их приготовления и применения

Also Published As

Publication number Publication date
US20080113021A1 (en) 2008-05-15
CN101528205A (zh) 2009-09-09
EP2094248A2 (en) 2009-09-02
CA2667207A1 (en) 2008-05-02
WO2008052033A3 (en) 2008-06-12
AU2007308986A1 (en) 2008-05-02
BRPI0718428A2 (pt) 2013-11-12
WO2008052033A2 (en) 2008-05-02

Similar Documents

Publication Publication Date Title
MX2009004439A (es) Composicion de ibuprofeno.
EP3492069A3 (en) Pharmaceutical compositions
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
IN2015DN03936A (es)
MY147641A (en) Fast release paracetamol tablets
WO2007048219A3 (en) Sustained drug release composition
WO2009041651A1 (ja) 速崩壊性固形製剤
NZ600640A (en) Abuse-resistant formulations
EP1750862A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING IRBESARTAN
WO2008128775A3 (en) Stabilised pharmaceutical composition containing pregabaline
WO2010033726A3 (en) Drug delivery composition comprising a self-assembled gelator
PL2020864T3 (pl) Sprasowana guma do żucia i sposób jej wytwarzania
AP3573A (en) Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes
MXPA05010607A (es) Composiciones de distribucion de farmacos de ester de alfa-hidroxiacido y metodos de uso.
WO2007134158A3 (en) Granules comprising calcium carbonate, a binder and a porosity increasing agent, processes of manufacturing, use in therapy
TN2011000261A1 (en) Octreotide depot formulation with constantly high exposure levels
WO2009117401A8 (en) Compositions for site-specific delivery of imatinib and methods of use
EA201001108A1 (ru) Диспергируемые во рту таблетки, содержащие основание эсциталопрама, и способ их получения
WO2009120389A8 (en) Oral and injectable formulations of tetracycline compounds
AR070593A1 (es) Composiciones efervescentes
MX2010008365A (es) Formulacion de liberacion sostenida que comprende octreotido y tres polimeros lineales de polilactido-co-glicolido.
UA95274C2 (ru) Твердый фармацевтический препарат, содержащий ирбесартан, и способы его изготовления
WO2007110765A3 (en) Processes for the preparation of octreotide
WO2007016315A3 (en) Extended release venlafaxine compositions
AU2003202550A1 (en) Pharmaceutical formulations with modified release

Legal Events

Date Code Title Description
FA Abandonment or withdrawal